Page 13 - Oncocyte News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oncocyte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oncocyte Today - Breaking & Trending Today
OncoCyte Co. (NASDAQ:OCX – Get Rating) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,420,000 shares, an increase of 22.4% from the May 15th total of 1,160,000 shares. Based on an average daily trading volume, of 531,600 shares, the days-to-cover ratio is […] ....
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a report published on Sunday morning. The firm issued a sell rating on the stock. Separately, Needham & Company LLC dropped their target price on shares of OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a report […] ....
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a report released on Friday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC decreased their target price on shares of OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a research report […] ....
StockNews.com started coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research note published on Friday. The firm issued a sell rating on the stock. OncoCyte Stock Down 2.1 % OCX opened at $0.22 on Friday. OncoCyte has a fifty-two week low of $0.20 and a fifty-two week high of $1.35. OncoCyte (NYSE:OCX […] ....
StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a report published on Friday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC cut their price objective on OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a report on Tuesday, April […] ....